Bio-Techne Corp (NASDAQ:TECH)’s traded shares stood at 0.51 million during the latest session, with the company’s beta value hitting 1.30. At the last check today, the stock’s price was $77.07, to imply a decrease of -1.94% or -$1.53 in intraday trading. The TECH share’s 52-week high remains $89.91, putting it -16.66% down since that peak but still an impressive 32.8% since price per share fell to its 52-week low of $51.79. The company has a valuation of $12.15B, with an average of 1.11 million shares over the past 3 months.
Bio-Techne Corp (NASDAQ:TECH) trade information
After registering a -1.94% downside in the latest session, Bio-Techne Corp (TECH) has traded red over the past five days. The stock hit a weekly high of 83.96, dropping -1.94% in its intraday price action. The 5-day price performance for the stock is -7.12%, and 21.93% over 30 days. With these gigs, the year-to-date price performance is -0.11%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bio-Techne Corp (TECH) estimates and forecasts
Looking at statistics comparing Bio-Techne Corp share performance against respective industry, we note that the company has underperformed competitors. Bio-Techne Corp (TECH) shares are 25.00% up over the last 6 months, with its year-to-date growth rate lower than industry average at -10.55% against 15.40%. The rating firms project that company’s revenue will grow 2.00% compared to the previous financial year.
Revenue forecast for the current quarter as set by 11 analysts is 306.76M. Meanwhile, for the current quarter, a total of 8 analyst(s) estimate revenue growth to 289.41M.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 16.30% for the past 5-year period. While 2024 is set for a -10.45% return in earnings, projections for the next 5 years are at 5.56% annually.
TECH Dividends
Bio-Techne Corp has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Bio-Techne Corp has a forward dividend ratio of 0.32, with the share yield ticking at 0.42% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
